Reading 9/17

Three Things I Found Interesting:

1.) I think the idea of digital therapeutics or other connected devices is a great way to improve the industry, The healthcare industry is seeming to try to think more like a business rather than a compilation of services. Thinking more like a business and at their patients as consumers rather than sick beings, they are able to take into account the needs and wants of the consumer outside of health. In this day in age even with the growing elderly population, a more digital approach to life is a must. Every aspect of a consumers life is just about run by technology so allowing patients to have access to an app or online tool for their treatment for their medical condition, makes their journey more efficient and effective. If the healthcare industry continues to have this outlook they will increase their customer satisfaction as well as build a tight-knit relationship.

2.) I think that is is interesting that the healthcare system is adopting ideas from business concepts that are used in terms of using consumer activity and data to influence purchase. How they are doing so is based on how consumers online shop or surf the web, they are creating digital healthcare solutions that on their phone that gives them a better idea of the best options to take when it comes to healthcare. This will ease their journey and allow insurance companies to better engagement of their members which will essentially end in cost saving.

3.) The pods resemble teams that project managers put together when they are trying to find out what their target market's wants and needs are. This connection between the two industries shows how more business oriented the healthcare industry is coming. They are caring more about patient care but they also what profit to rise by also helping out patients with their costs too. This connects to the ideas related last week in Dr. Welch's readings where it talked about how healthcare is moving towards intertwined care where all professions are on the same page with a patient. This is similar because now the insurer who carries much of the burden due to their financial aid, is now a more interactive member in the patients journey.


Three Questions:

1.) Will having digital therapeutics create more jobs or take jobs away due to its artificial intelligence? Can it be used in the pharmacy setting?
2.) Will implementing this new next generation member engagement create more jobs since now insurers have to complete more data mining and specify each members case in depth?
3.) Can anticipating or predicting patient decisions debilitate an insurer?

Comments

Post a Comment

Popular posts from this blog

Readings for 11/21

Three Interesting Things: 1.) I think it is interesting that some patients avoid treating their pain with opioids because of the negative connotation given by the media surrounding these drugs. Although, yes, they can be addictive there are ways to manage the intake so that you can both treat your pain and not become addicted. 2.) I think that the fact that patients could have to sign a narcotic contract to ensure that they will not go to fill the prescription at another pharmacy. I think that this is an excessive way to do this but I also feel that this is the only way to keep patients honest because of people within these situations these people cannot control their need. 3.) I think that it is interesting that this article brings up the topic of having pharmacists be more intuned with their work and be more educating for their patients. We have talked about often how pharmacists should have more of a comforting position with their patients and be able to have empathy for them. ...
Read more

Reading for 9/24

Three Interesting Things: 1.) I had no idea that the term "Clinical Research" only applied to studies and trials done on humans rather then animals or other test subjects. When grouping them all together you tend to have a broader or less abstract view of what the study actually entails but breaking down the term makes you start to separate the trial in your mind ahead of time. 2.) I think it is interesting that the FDA approves and regulates drug advertising but yet some companies still get away with falsifying their information about a drug when advertising it. There have been a multitude of law suits where patients experience a side affect or undesired outcome due to advertisements lacking certain information. With the most regulatory group approving all of this it is funky that some still slip through the cracks. 3.) I think that when it comes to naming drugs there is a laboratory name and then a manufacturing name. Its basically further splitting up the industry in...
Read more

Reflection 10/27

This week we learned about Federal Regulation with Dr. Baker. When it comes to regulation there is much to take in because there are many boxes to check state and federal wise. The US is one of the most efficient countries when it comes to regulating the drugs brought to market. The reason for doing so is because with healthcare resources being so scarce, there is no room for medical errors. This means that the regulatory committees want to get drugs to patients that are safe and effective that will not cause controversy in the future. The FDA's job is to decide what is actually considered a drug, whether this drug is going to need a prescription or can be over the counter, double check marketing efforts of the drug, and then finally make sure that all drugs that need proper FDA documentation have it. To those trying to experiment with drugs, they may see this process to be over bearing but it is specifically put in place to make sure that patients are receiving proper care. The ov...
Read more